Detalles de la búsqueda
1.
A Pooled Analysis of Pharmacokinetic Variability Information for Common Probe Substrates Used in Drug-Drug Interaction Studies.
Pharmacology;
101(3-4): 170-175, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29402842
2.
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
N Engl J Med;
370(3): 211-21, 2014 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24428467
3.
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
Liver Int;
36(2): 189-97, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26473667
4.
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
BMC Infect Dis;
16: 347, 2016 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27450277
5.
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
Gastroenterology;
146(2): 420-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24184132
6.
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
J Hepatol;
60(3): 490-9, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24444658
7.
Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
J Pharmacol Exp Ther;
344(3): 686-95, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23275065
8.
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.
Br J Clin Pharmacol;
75(1): 136-45, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22616739
9.
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
J Infect Dis;
206(7): 1002-11, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22896665
10.
Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C.
Antimicrob Agents Chemother;
56(4): 1838-44, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22290978
11.
Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
Chem Res Toxicol;
24(9): 1575-85, 2011 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-21728364
12.
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
Depress Anxiety;
27(5): 417-25, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20455246
13.
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors.
Nat Med;
26(5): 688-692, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32405062
14.
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis.
CPT Pharmacometrics Syst Pharmacol;
6(10): 695-704, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28699195
15.
A Review of Daclatasvir Drug-Drug Interactions.
Adv Ther;
33(11): 1867-1884, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27664109
16.
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
J Am Coll Cardiol;
43(5): 854-7, 2004 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-14998629
17.
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis C virus.
Clin Drug Investig;
34(9): 661-71, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117173
18.
Pharmacokinetics of the NS3 Protease Inhibitor, Asunaprevir (ASV, BMS-650032), in Phase I Studies in Subjects With or Without Chronic Hepatitis C.
Clin Pharmacol Drug Dev;
2(4): 316-27, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121936
19.
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy.
AIDS Res Hum Retroviruses;
29(10): 1287-92, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782005
20.
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aß levels in healthy young men.
Clin Drug Investig;
32(11): 761-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23018285